1 – 17 of 17
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Acromegaly management in the Nordic countries: A Delphi consensus survey
(
- Contribution to journal › Article
- 2022
-
Mark
Sinonasal Symptoms and Self-Reported Health before and after Endoscopic Pituitary Surgery-A Prospective Study
(
- Contribution to journal › Article
- 2021
-
Mark
Improved Urinary Cortisol Metabolome in Addison Disease : A Prospective Trial of Dual-Release Hydrocortisone
(
- Contribution to journal › Article
-
Mark
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease : a systematic review and meta-analysis
(
- Contribution to journal › Article
- 2020
-
Mark
Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission : A Swedish Nationwide Study
(
- Contribution to journal › Article
- 2019
-
Mark
The incidence of Cushing’s disease : a nationwide Swedish study
(
- Contribution to journal › Article
-
Mark
Overall and Disease-Specific Mortality in Patients With Cushing Disease: A Swedish Nationwide Study
(
- Contribution to journal › Article
- 2018
-
Mark
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency : a phase 3b, open-label, extension study
(
- Contribution to journal › Article
-
Mark
Clinical and immunological characteristics of autoimmune addison disease : A nationwide swedish multicenter study
(
- Contribution to journal › Article
- 2016
-
Mark
GH Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.
(
- Contribution to journal › Article
- 2015
-
Mark
The growth hormone receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population.
(
- Contribution to journal › Article
-
Mark
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
(
- Contribution to journal › Article
- 2014
-
Mark
Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
(
- Contribution to journal › Article
- 2013
-
Mark
Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy.
(
- Contribution to journal › Article
- 2007
-
Mark
Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone
(
- Contribution to journal › Article
-
Mark
Fracture incidence in GH-deficient patients on complete hormone replacement including GH
(
- Contribution to journal › Article